One Glove Group (5079) Fair Value & Analysis
Healthcare · MY · Market cap 72.8M MYR
Fair value as of: Jul 17, 2026
From 1 valuation models · updated 24 days ago
Fair value updated Jul 17, 2026, revised from 0.1400 MYR to 0.1900 MYR (+35.7%) since Jun 26, 2026. Share price −23.1% over the past month.
Below-average quality, screening 90% undervalued on our models.
What matters now
- The large discount to fair value meets weak quality (18/100). That raises the risk this is a value trap rather than a bargain.
- The price is below even our cautious bear case (0.1400 MYR). The market is more pessimistic than our downside scenario.
- The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
- A fairly wide model range (0.1400 MYR to 0.2900 MYR) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 17, 2026.
How to read this chart
60‑month range 0.1000 MYR – 2.71 MYR · fair‑value band 0.1400 MYR – 0.2900 MYR · the 0.1000 MYR price screens below the 0.1900 MYR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 17, 2026.
Analysis
One Glove Group (5079) currently trades at 0.1000 MYR, while our model-based Fair Value estimate is 0.1900 MYR, implying the stock looks roughly 90.0% undervalued today. The Quality Score stands at 18/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low), always confirm before acting.
Over the trailing twelve months, One Glove Group generated revenue of 39.5M MYR at a net margin of -99.1%. Revenue grew 43.2% year over year. It earns a return on equity of -26.9%. Net debt stands at 65.9M MYR. Fundamentals as of Jul 17, 2026
Our scenario range runs from 0.1400 MYR (bear case) to 0.2900 MYR (bull case); at 0.1000 MYR, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 50% below its 52-week high, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -43% fair-value upside, at 90%, 5079 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 1 models by family
Notify me when 5079 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 17, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 20 · Market factors (momentum, volatility) 22
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
One Glove Group Berhad, an investment holding company, manufactures, markets, and sells examination gloves and other related activities in Malaysia, Japan, Germany, the United States, India, and internationally. The company offers powder-free nitrile butadiene rubber medical examination and industrial gloves. It also sells fresh fruit bunches.
Full company description
One Glove Group Berhad, an investment holding company, manufactures, markets, and sells examination gloves and other related activities in Malaysia, Japan, Germany, the United States, India, and internationally. The company offers powder-free nitrile butadiene rubber medical examination and industrial gloves. It also sells fresh fruit bunches. The company was formerly known as GETS Global Berhad and changed its name to One Glove Group Berhad in July 2022. One Glove Group Berhad was incorporated in 2002 and is based in Kamunting, Malaysia.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2020 – FY2025 · reported fiscal years
One Glove Group reported revenue of 39.5M MYR in FY2025 versus 11.4M MYR in FY2020, a compound +28.2%/yr. Reported net income was −39.1M MYR in FY2025.
Watch 5079: get an alert when its fair value changes →
Peer Group
Medical Instruments & Supplies · 203 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Instruments & Supplies median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate (as of Jul 17, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Intuitive Surgical, Inc ISRG | $402.33 | $150.04 | -63% |
| EssilorLuxottica Société anonyme 1EL | €172.45 | €68.55 | -60% |
| Medline Inc MDLN | $41.11 | $30.15 | -27% |
| Becton, Dickinson and Company BDX | $150.65 | $103.53 | -31% |
| Alcon Inc ALC | $70.26 | $39.78 | -43% |
| ResMed Inc RMD | $203.87 | $187.89 | -8% |
| West Pharmaceutical Services, Inc WST | $353.71 | $143.97 | -59% |
| Straumann Holding STMN | CHF 106.00 | CHF 47.31 | -55% |
| Sartorius Stedim Biotech S.A DIM | €188.50 | €51.16 | -73% |
| Coloplast A/S COLOB | kr 414.00 | kr 382.22 | -8% |
Compare One Glove Group with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is One Glove Group (5079) overvalued or undervalued?
What is the fair value of 5079?
What is the quality score of 5079?
What is the revenue of One Glove Group (5079)?
What is the net profit margin of 5079?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track One Glove Group and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.